You are here: Industry Insights > Bayer

News List

US approval for OTC use of Bayer’s Astepro pharmatimes
June 22, 2021
The US Food and Drug Administration (FDA) has approved Bayer’s steroid-free antihistamine nasal spray Astepro for over-the-counter use.
Bayer and Zydus extend their JV for three years expresspharma
June 22, 2021
The joint venture will continue to operate in therapies including cardiology, diabetes, women’s health, ophthalmology and oncology, with new products in the pipeline.
Bayer subsidiary doses first patient with Parkinson’s disease cell therapy pharmatimes
June 10, 2021
German pharma company Bayer has announced that it has made progress in its ‘two-pronged’ approach to deliver cell and gene therapy candidates for the treatment of Parkinson’s disease.
Huma raises $130 million financing to scale its digital health platform for better care and research expresspharma
May 13, 2021
Huma’s platform combines predictive algorithms, digital biomarkers and real-world data to advance care and research.
Global pharmacovigilance market to value almost $15bn by 2028 europeanpharmaceuticalreview
April 29, 2021
Research suggests outsourcing and the increasing incidence of adverse drug reactions (ADR) will be primary drivers of growth in the global pharmacovigilance market.
FDA Releases Updated Essure Report americanpharmaceuticalreview
March 22, 2021
The U.S. Food and Drug Administration (FDA) posted the seventh spreadsheet of reportable adverse events that Bayer is required to submit as outlined in the April 24, 2020 variance from MDR reporting requirements.
Bayer wins ‘Best Employer in India’ Award from Kincentric expresspharma
March 19, 2021
Bayer has been named by Kincentric as one of India’s “Best Employers” for 2020. This is the fourth consecutive year since 2017 that Bayer has bagged this award.
Bayer reports steady 2020 performance despite Covid-19 pandemic pharmaceutical-technology
February 26, 2021
German-headquartered pharma company Bayer has published its 2020 annual report. The report suggests that Bayer had a robust 2020 despite the Covid-19 pandemic and there was positive momentum for solid operational growth in 2021, the company said.
Bayer to manufacture mRNA vaccine in Germany worldpharmanews
February 02, 2021
In a joint press briefing yesterday together with German Health Minister Jens Spahn, Minister-President of North Rhine-Westphalia, Armin Laschet, and Chief Executive Officer of CureVac N.V., Franz-Werner Haas, Member of the Board of Management ...
Bayer’s Xarelto approved in the UK pharmatimes
February 02, 2021
Bayer’s oral factor Xa inhibitor Xarelto (rivaroxaban) has been approved in the UK to treat venous thromboembolism (VTE) and to prevent VTE recurrence in children.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 20 21 Next page